zoledronic acid has been researched along with Diabetes Mellitus, Adult-Onset in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bhansali, A; Das, L; Dutta, P; Jude, EB; Prakash, M; Rastogi, A | 1 |
| Kamalanathan, S; Kar, SS; Merugu, C; Naik, D; Narayanan, N; Patel, D; Ramkumar, G; Reddy, SVB; Roy, A; Sahoo, J; Suryadevara, V | 1 |
| Abe, T; Kishimoto, H; Nishioka, T; Segawa, E; Shinohara, M; Takaoka, K; Tamaoka, J; Ueda, H; Urade, M; Yamamura, M | 1 |
| Elad, S; Hardan, I; Lazarovici, TS; Taicher, S; Yahalom, R; Yarom, N | 1 |
| Nwachukwu, U | 1 |
| Collet, P; Marotte, H; Nizeica, V | 1 |
| Bishop, PA; Hay, KD | 1 |
1 trial(s) available for zoledronic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Topics: Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Osteogenesis; Treatment Outcome; Zoledronic Acid | 2021 |
6 other study(ies) available for zoledronic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effect of a single dose of zoledronic acid on bone mineral density and trabecular bone score in Indian postmenopausal osteoporotic women with and without type 2 diabetes mellitus - A prospective cohort pilot study.
Topics: Absorptiometry, Photon; Bone Density; Cancellous Bone; Diabetes Mellitus, Type 2; Female; Humans; Lumbar Vertebrae; Osteoporotic Fractures; Pilot Projects; Postmenopause; Prospective Studies; Zoledronic Acid | 2023 |
Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Topics: Acid Phosphatase; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density; Bone Remodeling; Diabetes Mellitus, Type 2; Diphosphonates; Disease Models, Animal; Gene Expression; Humans; Imidazoles; Injections, Intravenous; Isoenzymes; Male; Maxilla; Molar; Osteoclasts; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Tartrate-Resistant Acid Phosphatase; Tooth Extraction; Zoledronic Acid | 2015 |
Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alendronate; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Minimally Invasive Surgical Procedures; Oral Surgical Procedures; Osteonecrosis; Pamidronate; Risk Factors; Smoking; Time Factors; Treatment Outcome; Wound Healing; Zoledronic Acid | 2009 |
Health trends.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Bone Density Conservation Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Diabetes Mellitus, Type 2; Diphosphonates; Drug Therapy; Dyslipidemias; Enoxaparin; Fibrinolytic Agents; Fractures, Bone; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Imidazoles; Middle Aged; Neoplasm Staging; Pharmacy; Pyrazoles; Pyridones; Salicylates; Treatment Outcome; Venous Thromboembolism; Young Adult; Zoledronic Acid | 2010 |
Bortezomib induced a phrenic palsy in a multiple myeloma patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Boronic Acids; Bortezomib; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Diphosphonates; gamma-Aminobutyric Acid; Humans; Imidazoles; Male; Melphalan; Multiple Myeloma; Nerve Compression Syndromes; Neuralgia; Phrenic Nerve; Prednisone; Pregabalin; Protease Inhibitors; Pyrazines; Respiratory Paralysis; Zoledronic Acid | 2013 |
Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Density Conservation Agents; Carcinoma; Diabetes Mellitus, Type 2; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Patient Care Planning; Tooth Extraction; Zoledronic Acid | 2006 |